Guardant Health
Precision-oncology company providing blood- and tissue-based tests for cancer screening, molecular profiling, therapy selection, and recurrence monitoring.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
NA · Recruiting · Bladder Carcinoma
Shield Post-Approval Study ProtocolNA · Recruiting · Colo-rectal Cancer
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuationNA · Recruiting · Non-small Cell Lung Cancer
Decision Counseling and Follow-up for Shield+ PatientsNA · Not Yet Recruiting · Colo-rectal Cancer
Screening for High Frequency Malignant DiseaseNA · Active Not Recruiting · Lung Cancer
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening EpisodeNA · Active Not Recruiting · Colorectal Cancer
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/guardant-health/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.